287 research outputs found
Determining factors of functioning in hemodialysis patients using the international classification of functioning, disability and health
Background: Hemodialysis (HD) treatment affects functioning, physical activity level, clinical biomarkers, and body
composition. However, the association between these variables with functioning, considering International Classification
of Functioning, Disability and Health (ICF) domains remains unclear. Thus, the aim of this study was to investigate
the possible association between physical activity, biomarkers, and body composition with functioning in HD patients
in reference to the ICF.
Methods: Eighty HD patients performed different tests grouped according to ICF domain: Body structure and function
– handgrip strength (HS), 5-repetition sit-to-stand test, and 60-s sit-to-stand test (5-STS, 60-STS, respectively);
Activity – short physical performance battery (SPPB); and Participation – participation scale questionnaire. Physical
activity [Human Activity Profile questionnaire (HAP)], body composition (Dual-energy X-ray absorptiometry), Parathormone
(PTH), and alkaline phosphatase were analyzed as possible variables associated with ICF domains. Data analyses
were performed using simple and multiple regression models adjusted for age, duration of HD, and diuresis volume.
Results: In the body structure and function domain, appendicular lean mass, PTH level, and age were associated
with HS (
R2 = 0.558); HAP and PTH were associated with 5-STS (
R2 = 0.263); and HAP, PTH, duration of HD, and age
were associated with 60-STS (
R2 = 0.337). In the activity domain, HAP, PTH, alkaline phosphatase, duration of HD, age,
and body fat were associated with SPPB (
R2 = 0.689). Finally, only HAP was associated with the participation scale
(
R2 = 0.067).
Conclusion: Physical activity and PTH levels are determinant protagonists of functioning in all ICF domains in hemodialysis
patients
Atividade antinociceptiva de Ipomoea imperati (Vahl) Griseb., Convolvulaceae
Ipomoea imperati (Vahl) Griseb., Convolvulaceae, is used in folk medicine for the treatment of inflammation, swelling and wounds, as well as to treat pains after childbirth and for stomach problems. Administration of ethanol extract, lipid and aqueous fraction of I. imperati(300, 100 and 200 mg/kg) significantly inhibited the abdominal constriction in mice induced by acetic acid; increased the sleeping time evoked by pentobarbital sodium and showed a significant activity by inhibiting formalin-induced paw edema in mice. The same dose of I. imperatialso raised the pain of mice in the hot-plate test and increased the latency at all observation times. The pre-treatment of the animals with naloxone (5 mg/kg, i.p.) suggested the participation of the opioid system in the antinociceptive effect of Ipomoea imperati.A espécie vegetal Ipomoea imperati (Vahl) Griseb., Convolvulaceae, é usada popularmente para tratar inflamação, inchaço e feridas, bem como para tratar dor após o parto e dor estomacal. A administração do extrato etanólico e das frações lipídica e aquosa de I. imperati(300, 100 e 200 mg/kg) inibiu significativamente as contrações abdominais em camundongo induzidas por ácido acético, aumentou o tempo de sono evocado por pentobarbital sódico e mostrou significativa atividade inibitória sobre o edema de pata de camundongo induzido por formalina. As mesmas doses de I. imperati(300, 100 e 200 mg/kg) também elevou a latência de todos os tempos observados no teste da placa quente. O pré-tratamento de animais com naloxona (5 mg/kg, i.p) sugere a participação do sistema opioide no efeito anti-nociceptivo de Ipomoea imperati
Atividade antinociceptiva de Ipomoea imperati (Vahl) Griseb., Convolvulaceae
Ipomoea imperati (Vahl) Griseb., Convolvulaceae, is used in folk medicine for the treatment of inflammation, swelling and wounds, as well as to treat pains after childbirth and for stomach problems. Administration of ethanol extract, lipid and aqueous fraction of I. imperati(300, 100 and 200 mg/kg) significantly inhibited the abdominal constriction in mice induced by acetic acid; increased the sleeping time evoked by pentobarbital sodium and showed a significant activity by inhibiting formalin-induced paw edema in mice. The same dose of I. imperatialso raised the pain of mice in the hot-plate test and increased the latency at all observation times. The pre-treatment of the animals with naloxone (5 mg/kg, i.p.) suggested the participation of the opioid system in the antinociceptive effect of Ipomoea imperati.A espécie vegetal Ipomoea imperati (Vahl) Griseb., Convolvulaceae, é usada popularmente para tratar inflamação, inchaço e feridas, bem como para tratar dor após o parto e dor estomacal. A administração do extrato etanólico e das frações lipídica e aquosa de I. imperati(300, 100 e 200 mg/kg) inibiu significativamente as contrações abdominais em camundongo induzidas por ácido acético, aumentou o tempo de sono evocado por pentobarbital sódico e mostrou significativa atividade inibitória sobre o edema de pata de camundongo induzido por formalina. As mesmas doses de I. imperati(300, 100 e 200 mg/kg) também elevou a latência de todos os tempos observados no teste da placa quente. O pré-tratamento de animais com naloxona (5 mg/kg, i.p) sugere a participação do sistema opioide no efeito anti-nociceptivo de Ipomoea imperati.20218018
Comparative assessment of skin reactivity to thimerosal- or phenol-preserved Imunoleish® antigen in dogs with suspected American Tegumentary Leishmaniasis in an endemic area of the state of Rio de Janeiro, Brazil
The leishmanin skin test (LST), which is an in vivo test that assesses the cellular immune responses to Leishmania-derived antigens, is an important tool in the laboratory diagnosis of American tegumentary leishmaniasis (ATL). This study aimed to compare the results obtained in LST employing the Imunoleish® antigen preserved with thimerosal (AgT) or phenol (AgP) and serological techniques to detect a possible infection caused by Leishmania (Viannia) braziliensis in dogs. The study included 172 dogs from an area endemic for ATL in the municipality of Paracambi, state of Rio de Janeiro, Brazil. The results obtained with Imunoleish® antigen preserved with thimerosal (AgT) or phenol (AgP) and serological tests were compared. Each dog received, intradermally, 0.1 mL of each antigen on the inner side of the right (AgT) and left (AgP) thighs. Five (2.7%) dogs presented ATL lesions. Of these, two were reactive to both formulations and three were reactive only to AgT. Among the 172 dogs, 68 (39.5%) were reactive only to AgT, 16 (9.3%) only to AgP, and 11 (6.4%) to both formulations. Twenty-one (12.2%) sera samples were reactive by immunofluorescent antibody test (IFAT) and 21 enzyme-linked immunosorbent assay (ELISA). However, in only two dogs out of the five which Leishmania was isolated from, serological tests were positive. The LST and serological tests could be a useful tool in the diagnosis of L. (V.) braziliensis infection in dogs. Standardization of the techniques and reagents used could allow comparative studies on sensitivity, specificity, and positive and negative predictive values in dogs from different regions.Keywords: American Tegumentary Leishmaniasis, Leishmanin skin test, Diagnosis, Dogs, Host
Atividade antinociceptiva de ipomoea imperati (vahl) griseb., convolvulaceae
Ipomoea imperati (Vahl) Griseb., Convolvulaceae, is used in folk medicine for the treatment of inflammation, swelling and wounds, as well as to treat pains after childbirth and for stomach problems. Administration of ethanol extract, lipid and aqueous fraction of I. imperati(300, 100 and 200 mg/kg) significantly inhibited the abdominal constriction in mice induced by acetic acid; increased the sleeping time evoked by pentobarbital sodium and showed a significant activity by inhibiting formalin-induced paw edema in mice. The same dose of I. imperatialso raised the pain of mice in the hot-plate test and increased the latency at all observation times. The pre-treatment of the animals with naloxone (5 mg/kg, i.p.) suggested the participation of the opioid system in the antinociceptive effect of Ipomoea imperati202180185A espécie vegetal Ipomoea imperati (Vahl) Griseb., Convolvulaceae, é usada popularmente para tratar inflamação, inchaço e feridas, bem como para tratar dor após o parto e dor estomacal. A administração do extrato etanólico e das frações lipídica e aquosa de I. imperati(300, 100 e 200 mg/kg) inibiu significativamente as contrações abdominais em camundongo induzidas por ácido acético, aumentou o tempo de sono evocado por pentobarbital sódico e mostrou significativa atividade inibitória sobre o edema de pata de camundongo induzido por formalina. As mesmas doses de I. imperati(300, 100 e 200 mg/kg) também elevou a latência de todos os tempos observados no teste da placa quente. O pré-tratamento de animais com naloxona (5 mg/kg, i.p) sugere a participação do sistema opioide no efeito anti-nociceptivo de Ipomoea imperat
Anti-IL-2 Treatment Impairs the Expansion of Treg Cell Population during Acute Malaria and Enhances the Th1 Cell Response at the Chronic Disease
Plasmodium chabaudi infection induces a rapid and intense splenic CD4+ T cell response that contributes to both disease pathogenesis and the control of acute parasitemia. The subsequent development of clinical immunity to disease occurs concomitantly with the persistence of low levels of chronic parasitemia. The suppressive activity of regulatory T (Treg) cells has been implicated in both development of clinical immunity and parasite persistence. To evaluate whether IL-2 is required to induce and to sustain the suppressive activity of Treg cells in malaria, we examined in detail the effects of anti-IL-2 treatment with JES6-1 monoclonal antibody (mAb) on the splenic CD4+ T cell response during acute and chronic P. chabaudi AS infection in C57BL/6 mice. JES6-1 treatment on days 0, 2 and 4 of infection partially inhibits the expansion of the CD4+CD25+Foxp3+ cell population during acute malaria. Despite the concomitant secretion of IL-2 and expression of high affinity IL-2 receptor by large CD4+ T cells, JES6-1 treatment does not impair effector CD4+ T cell activation and IFN-γ production. However, at the chronic phase of the disease, an enhancement of cellular and humoral responses occurs in JES6-1-treated mice, with increased production of TNF-α and parasite-specific IgG2a antibodies. Furthermore, JES6-1 mAb completely blocked the in vitro proliferation of CD4+ T cells from non-treated chronic mice, while it further increased the response of CD4+ T cells from JES6-1-treated chronic mice. We conclude that JES6-1 treatment impairs the expansion of Treg cell population during early P. chabaudi malaria and enhances the Th1 cell response in the late phase of the disease
Human Paraoxonase Gene Polymorphisms and Coronary Artery Disease Risk
Introdução: As doenças complexas como a
doença das artérias coronárias (DAC), a
hipertensão e a diabetes, são usualmente
causadas pela susceptibilidade individual a
múltiplos genes, factores ambientais e pela
interacção entre eles. As enzimas da
paraoxonase humana (PON), particularmente a
PON1, têm sido implicadas na patogenia da
aterosclerose e da DAC. Dois polimorfismos
comuns na região codificante do gene, com
substituição Glutamina (Q) /Arginina (R) na
posição 192 e Leucina /Metionina na posição
55 influenciam a actividade da PON1. Vários
estudos têm investigado a associação entre os
polimorfismos da PON1 e a DAC, com
resultados contraditórios.
Objectivo: 1- Avaliar a associação dos
polimorfismos da PON1 com o risco de DAC.
2-Estudar a interacção destes polimorfismos
com outros situados em genes candidatos
diferentes, na susceptibilidade para o
aparecimento da DAC.
Material e Métodos: Estudámos em 298
doentes coronários e 298 controlos saudáveis,
através de um estudo caso/controlo, o risco de
DAC associado aos polimorfismos da PON1,
192Q/R e 55L/M. Numa segunda fase
avaliámos o risco das interacções polimórficas
PON1 192 RR + MTHFR 1298 AA; PON1
192 R/R + ECA DD; PON1 192 R/R + ECA 8
GG. Finalmente construímos um modelo de
regressão logística (no qual entraram todas as
variáveis genéticas, ambientais e bioquímicas,
que tinham mostrado significância estatística
na análise univariada), para determinar quais
as que se relacionavam de forma significativa e
independente com DAC.
Resultados: Verificámos que o genótipo PON155 MM tinha uma distribuição superior na
população doente mas não atingia significância
estatística como factor de risco para DAC. O
PON1 199 RR apresentou um risco relativo
80% superior relativamente à população que o
não possuía (p=0,04). A interacção da PON1
192 RR e da MTHFR 1298 AA, polimorfismos
sedeados em genes diferentes, apresentou um
risco relativo de DAC de 2,76
(OR=2,76;IC=1,20- 6,47; P=0,009), bastante
superior ao risco de cada polimorfismo isolado,
assim como a associação da PON1 RR + ECA
DD (com polimorfismos também sedeados em
genes diferentes), que apresentou um risco
337% superior relativamente aos que não
possuíam esta associação (OR=4,37;IC=1,47-
13,87; P=0,002). Da mesma forma a associação
entre a PON1 RR e ECA 8 GG, revelou um
risco ainda mais elevado (OR=6;23; IC=1,67-
27,37; P<0,001). Após modelo de Regressão
Logística as variáveis que ficaram na equação
representando factores de risco significativos e
independentes para DAC, foram os hábitos
tabágicos, doença familiar, diabetes,
fibrinogénio, Lp (a) e a associação PON1 192
RR + ECA 8 GG. Esta última associação
apresentou, na regressão logística, um
OR=14,113; p=0,018
Conclusões: O genótipo PON1 192 RR
apresentou, se avaliado isoladamente, um risco
relativo de DAC 80% superior relativamente à
população que não possuía este genótipo. A
associação deste polimorfismo com outros
polimorfismos sedeados em genes diferentes,
codificando para diferentes enzimas e
pertencendo a sistemas fisiopatológicos
distintos (MTHFR1298 AA, ECA DD e ECA 8
GG), aumentou sempre o risco de eclosão da
DAC. Após correcção para os outros factores
de risco clássicos e bioquímicos, a associação
PON1 192 RR + ECA 8 GG, continuou a ser
um factor de risco significativo e independente
para CAD.Background: Complex diseases such as
coronary artery disease (CAD), hypertension
and diabetes are usually caused by individual
susceptibility to multiple genes, environmental
factors, and the interaction between them. The
paraoxonase 1 (PON1) enzyme has been
implicated in the pathogenesis of
atherosclerosis and CAD. Two common
polymorphisms in the coding region of the
PON1 gene, which lead to a glutamine
(Q)/arginine (R) substitution at position 192
and a leucine (L)/methionine (M) substitution
at position 55, influence PON1 activity. Studies
have investigated the association between these
polymorphisms and CAD, but with conflicting
results.
Aims: 1) To evaluate the association between
PON1 polymorphisms and CAD risk; and 2) to
study the interaction between PON1
polymorphisms and others in different
candidate genes.
Methods: We evaluated the risk of CAD
associated with PON1 Q192R and L55M
polymorphisms in 298 CAD patients and 298
healthy individuals. We then evaluated the risk
associated with the interaction of the PON1
polymorphisms with ACE DD, ACE 8 GG and
MTHFR 1298AA. Finally, using a logistic
regression model, we evaluated which variables
(genetic, biochemical and environmental) were
linked significantly and independently with
CAD.
Results: We found that the PON1 55MM
genotype was more common in the CAD population, but this did not reach statistical
significance as a risk factor for CAD, while
PON1 192RR presented an 80% higher
relative risk compared to the population
without this polymorphism. The interaction
between PON1 192RR and MTHFR 1298AA,
sited in different genes, increased the risk for
CAD, compared with the polymorphisms in
isolation (OR=2.76; 95% CI=1.20-6.47;
p=0.009), as did the association of PON1
192RR with ACE DD, which presented a
337% higher risk compared to the population
without this polymorphic association
(OR=4.37; 95% CI=1.47-13.87; p=0.002).
Similarly, the association between PON1
192RR and ACE 8 GG was linked to an even
higher risk (OR=6.23; 95% CI=1.67-27.37;
p<0.001). After logistic regression, smoking,
family history, fibrinogen, diabetes, Lp(a) and
the association of PON1 192RR + ACE 8 GG
remained in the regression model and proved
to be significant and independent risk factors
for CAD. In the regression model the latter
association had OR=14.113; p=0.018.
Conclusion: When analyzed separately, the
PON1 192RR genotype presented a relative
risk for CAD 80% higher than in the
population without this genotype. Its
association with other genetic polymorphisms
sited in different genes, coding for different
enzymes and belonging to different
physiological systems, always increased the
risk for CAD. After correction for other
conventional and biochemical risk factors, the
PON1 192RR + ACE 8 GG association
remained a significant and independent risk
factor for CAD.info:eu-repo/semantics/publishedVersio
Síndrome de Pendred causada por mutação em homozigoze no gene SLC26A4 em uma família brasileira consangüínea
ABSTRACTPendred Syndrome (PS) is an autossomal recessive disorder characterized by sensorineural deafness, goiter and iodide organification defect. The hearing loss is associated with inner ear abnormalities, ranging from an isolated enlarged vestibular aqueduct (EVA) to a typical coclear dysplasia. Mutations in the gene that encodes pendrin (SLC26A4), a chloride/iodide transporter, have been shown to be associated with PS. We describe the clinical and molecular characteristics of a large consanguineous family harboring a mutation in the SLC26A4 gene. The proband was a 26-year-old deaf Brazilian woman who presented a bulky multinodular goiter and hypothyroidism since puberty. Five other siblings were deaf: one brother had a similar phenotype, three siblings also had goiters but normal thyroid function tests, and one brother had only a subtle thyroid enlargement. Other 4 siblings had no thyroid or hearing disorder. Parents were first degree cousins and had normal hearing. The mother was healthy, except for subclinical hypothyroidism; the father was deceased. A perchlorate test in the proband showed a discharge of 21% of the incorporated iodide 2h after the administration of 1g of KClO4. Audiological examinations showed profound hearing loss in all deaf subjects; CT and MRI of the temporal bones showed EVA in all of them. Genomic DNA was isolated from whole blood, from the 6 affected and 4 unaffected siblings, the mother and control. The coding region of the PDS gene (exons 2-21), including exon/intron boundaries, were amplified by PCR and sequenced. A single base-pair (T) deletion at position 1197 of exon 10 was detected in homozygous state in the 6 deaf siblings. The mother and 2 unaffected siblings were heterozygous for this mutation, which has been described by Everett et al. The 1197delT mutation is predicted to result in a frameshift and a truncated protein. The existence of PS phenocopies and intrafamilial phenotypic variability are well documented. The definite diagnosis requires molecular analysis. Our study illustrates the value and challenges of mutational analysis in selected patients with PS. __________________________________________________________________________________ RESUMOA syndrome de Pendred (SP) é uma doença autossômica recessiva caracterizada por surdez neurossensorial, bócio e defeito de organificação do iodo. A perda auditiva está associada a anormalidades do ouvido interno, desde a dilatação isolada do aqueduto vestibular (DAV) até uma típica displasia coclear. Mutações no gene que codifica a pendrina (SLC26A4), um transportador de cloreto/iodeto, têm sido associadas à SP. Descrevemos as características clínicas e moleculares de uma grande família consangüínea portadora de uma mutação no gene SLC26A4. O caso-índice era uma paciente do sexo feminino, brasileira, 26 anos, portadora de surdez congênita, que apresentava um volumoso bócio multinodular e hipotireoidismo desde a puberdade. Outros cinco irmãos eram surdos: um irmão tinha fenotipo semelhante, três também tinham bócio, porém com função tiroideana normal e um irmão tinha apenas um discreto aumento da tiróide. Outros quatro irmãos não apresentavam alteração tiroideana ou auditiva. Os pais eram primos de primeiro grau e tinham audição normal. A mãe era saudável, exceto por hipotireoidismo subclínico; o pai era falecido. O teste do perclorato no caso-índice revelou a liberação de 21% do iodo incorporado duas horas após a administração de 1 g de KClO4. Os exames audiológicos mostraram perda auditiva profunda em todos os indivíduos afetados; TC e RMN dos ossos temporais mostraram DAV em todos eles. O DNA genômico foi isolado do sangue total dos seis irmãos afetados e dos quatro não-afetados, da mãe e do controle. A região codificante do gene PDS (éxons 2-21), incluindo as junções éxon/íntron, foram amplificadas por PCR e seqüenciadas. Foi detectada a deleção de uma base (T) na posição 1197 do éxon 10, em homozigoze, nos seis irmãos afetados. A mãe e dois irmãos não-afetados eram heterozigotos para a mutação, que foi descrita inicialmente por Everett e cols. A mutação 1197delT provavelmente resulta em um erro de fase de leitura (frameshift) e em uma proteína truncada. A existência de fenocópias da SP e a variabilidade fenotípica intrafamiliar são bem conhecidas. O diagnóstico definitivo requer análise molecular. O presente estudo ilustra o valor e os desafios da análise mutacional em pacientes selecionados com SP
- …